Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease

The messenger RNAs for the angiogenic acidic and basic fibroblast growth factors are expressed at a significantly higher level in samples of human benign neoplastic and hyperplastic tissue than in samples from breast cancers. However, approximately one in four malignant breast cancer samples contain...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of cancer 1994-04, Vol.69 (4), p.772-776
Hauptverfasser: ANANDAPPA, S. Y, WINSTANLEY, J. H. R, LEINSTER, S, GREEN, B, RUDLAND, P. S, BARRACLOUGH, R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 776
container_issue 4
container_start_page 772
container_title British journal of cancer
container_volume 69
creator ANANDAPPA, S. Y
WINSTANLEY, J. H. R
LEINSTER, S
GREEN, B
RUDLAND, P. S
BARRACLOUGH, R
description The messenger RNAs for the angiogenic acidic and basic fibroblast growth factors are expressed at a significantly higher level in samples of human benign neoplastic and hyperplastic tissue than in samples from breast cancers. However, approximately one in four malignant breast cancer samples contain basic fibroblast growth factor mRNA at the same level as in the benign lesions when basic fibroblast growth factor mRNA levels are corrected with respect to levels of expression of glyceraldehyde-3-phosphate dehydrogenase mRNA. A similar proportion of human malignant breast cancer cell lines express a high level of basic fibroblast growth factor mRNA. The results suggest that some malignant breast cancers and their constitutive carcinoma cells express abundant levels of basic fibroblast growth factor mRNA. The resultant production of basic fibroblast growth factor by breast cancer cells within some tumours may contribute to their development.
doi_str_mv 10.1038/bjc.1994.146
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1968831</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76410652</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3486-b5db313f8a7d63ec30405207f0789c79d65cbee2016068979766c3e40ccb75c73</originalsourceid><addsrcrecordid>eNpVkc9rFDEYhoModV29eRVyEE_O-mUyk0wuQln8BaUF0XNIMt9sU2aSNZlt7X_fDLssevoS3iffG3gIectgw4B3n-yd2zClmg1rxDOyYi2vK9bV8jlZAYCsQNXwkrzK-a5cFXTyglzIlrEGxIrobZz2JpnZ3yPFv_uEOfsYaBzo4G2KdjR5prsUH-ZbOhg3x0Snn9eXmfpALQa_C9SEnk5mLEcTZmoTLk96n8vE1-TFYMaMb05zTX5__fJr-726uvn2Y3t5VTnedKKybW8540NnZC84Og4NtDXIAWSnnFS9aJ1FrIEJEJ2SSgrhODbgnJWtk3xNPh_37g92wt5hmJMZ9T75yaRHHY3X_yfB3-pdvNdMia4r1Wvy4bQgxT8HzLOefHY4jiZgPGQtRcNAtHUBPx5Bl2LOCYdzCQO9CNFFiF6E6CKk4O_-_dgZPhko-ftTbrIz45BMcD6fsQaghVoVjB6xYOZDwnNeupaqpekJ_safow</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76410652</pqid></control><display><type>article</type><title>Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease</title><source>MEDLINE</source><source>Nature</source><source>Springer Nature - Complete Springer Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>ANANDAPPA, S. Y ; WINSTANLEY, J. H. R ; LEINSTER, S ; GREEN, B ; RUDLAND, P. S ; BARRACLOUGH, R</creator><creatorcontrib>ANANDAPPA, S. Y ; WINSTANLEY, J. H. R ; LEINSTER, S ; GREEN, B ; RUDLAND, P. S ; BARRACLOUGH, R</creatorcontrib><description>The messenger RNAs for the angiogenic acidic and basic fibroblast growth factors are expressed at a significantly higher level in samples of human benign neoplastic and hyperplastic tissue than in samples from breast cancers. However, approximately one in four malignant breast cancer samples contain basic fibroblast growth factor mRNA at the same level as in the benign lesions when basic fibroblast growth factor mRNA levels are corrected with respect to levels of expression of glyceraldehyde-3-phosphate dehydrogenase mRNA. A similar proportion of human malignant breast cancer cell lines express a high level of basic fibroblast growth factor mRNA. The results suggest that some malignant breast cancers and their constitutive carcinoma cells express abundant levels of basic fibroblast growth factor mRNA. The resultant production of basic fibroblast growth factor by breast cancer cells within some tumours may contribute to their development.</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/bjc.1994.146</identifier><identifier>PMID: 7511406</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>Basingstoke: Nature Publishing Group</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Blotting, Northern ; Breast Diseases - metabolism ; Breast Neoplasms - chemistry ; Breast Neoplasms - metabolism ; DNA Probes ; Female ; Fibroblast Growth Factor 1 - biosynthesis ; Fibroblast Growth Factor 2 - biosynthesis ; Glyceraldehyde-3-Phosphate Dehydrogenases - biosynthesis ; Gynecology. Andrology. Obstetrics ; Humans ; Mammary gland diseases ; Medical sciences ; Middle Aged ; Poly A - analysis ; RNA, Messenger - analysis ; RNA, Neoplasm - analysis ; Tumor Cells, Cultured ; Tumors</subject><ispartof>British journal of cancer, 1994-04, Vol.69 (4), p.772-776</ispartof><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3486-b5db313f8a7d63ec30405207f0789c79d65cbee2016068979766c3e40ccb75c73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968831/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968831/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,27911,27912,53778,53780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4005029$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7511406$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ANANDAPPA, S. Y</creatorcontrib><creatorcontrib>WINSTANLEY, J. H. R</creatorcontrib><creatorcontrib>LEINSTER, S</creatorcontrib><creatorcontrib>GREEN, B</creatorcontrib><creatorcontrib>RUDLAND, P. S</creatorcontrib><creatorcontrib>BARRACLOUGH, R</creatorcontrib><title>Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><description>The messenger RNAs for the angiogenic acidic and basic fibroblast growth factors are expressed at a significantly higher level in samples of human benign neoplastic and hyperplastic tissue than in samples from breast cancers. However, approximately one in four malignant breast cancer samples contain basic fibroblast growth factor mRNA at the same level as in the benign lesions when basic fibroblast growth factor mRNA levels are corrected with respect to levels of expression of glyceraldehyde-3-phosphate dehydrogenase mRNA. A similar proportion of human malignant breast cancer cell lines express a high level of basic fibroblast growth factor mRNA. The results suggest that some malignant breast cancers and their constitutive carcinoma cells express abundant levels of basic fibroblast growth factor mRNA. The resultant production of basic fibroblast growth factor by breast cancer cells within some tumours may contribute to their development.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Blotting, Northern</subject><subject>Breast Diseases - metabolism</subject><subject>Breast Neoplasms - chemistry</subject><subject>Breast Neoplasms - metabolism</subject><subject>DNA Probes</subject><subject>Female</subject><subject>Fibroblast Growth Factor 1 - biosynthesis</subject><subject>Fibroblast Growth Factor 2 - biosynthesis</subject><subject>Glyceraldehyde-3-Phosphate Dehydrogenases - biosynthesis</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Mammary gland diseases</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Poly A - analysis</subject><subject>RNA, Messenger - analysis</subject><subject>RNA, Neoplasm - analysis</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkc9rFDEYhoModV29eRVyEE_O-mUyk0wuQln8BaUF0XNIMt9sU2aSNZlt7X_fDLssevoS3iffG3gIectgw4B3n-yd2zClmg1rxDOyYi2vK9bV8jlZAYCsQNXwkrzK-a5cFXTyglzIlrEGxIrobZz2JpnZ3yPFv_uEOfsYaBzo4G2KdjR5prsUH-ZbOhg3x0Snn9eXmfpALQa_C9SEnk5mLEcTZmoTLk96n8vE1-TFYMaMb05zTX5__fJr-726uvn2Y3t5VTnedKKybW8540NnZC84Og4NtDXIAWSnnFS9aJ1FrIEJEJ2SSgrhODbgnJWtk3xNPh_37g92wt5hmJMZ9T75yaRHHY3X_yfB3-pdvNdMia4r1Wvy4bQgxT8HzLOefHY4jiZgPGQtRcNAtHUBPx5Bl2LOCYdzCQO9CNFFiF6E6CKk4O_-_dgZPhko-ftTbrIz45BMcD6fsQaghVoVjB6xYOZDwnNeupaqpekJ_safow</recordid><startdate>19940401</startdate><enddate>19940401</enddate><creator>ANANDAPPA, S. Y</creator><creator>WINSTANLEY, J. H. R</creator><creator>LEINSTER, S</creator><creator>GREEN, B</creator><creator>RUDLAND, P. S</creator><creator>BARRACLOUGH, R</creator><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19940401</creationdate><title>Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease</title><author>ANANDAPPA, S. Y ; WINSTANLEY, J. H. R ; LEINSTER, S ; GREEN, B ; RUDLAND, P. S ; BARRACLOUGH, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3486-b5db313f8a7d63ec30405207f0789c79d65cbee2016068979766c3e40ccb75c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Blotting, Northern</topic><topic>Breast Diseases - metabolism</topic><topic>Breast Neoplasms - chemistry</topic><topic>Breast Neoplasms - metabolism</topic><topic>DNA Probes</topic><topic>Female</topic><topic>Fibroblast Growth Factor 1 - biosynthesis</topic><topic>Fibroblast Growth Factor 2 - biosynthesis</topic><topic>Glyceraldehyde-3-Phosphate Dehydrogenases - biosynthesis</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Mammary gland diseases</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Poly A - analysis</topic><topic>RNA, Messenger - analysis</topic><topic>RNA, Neoplasm - analysis</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ANANDAPPA, S. Y</creatorcontrib><creatorcontrib>WINSTANLEY, J. H. R</creatorcontrib><creatorcontrib>LEINSTER, S</creatorcontrib><creatorcontrib>GREEN, B</creatorcontrib><creatorcontrib>RUDLAND, P. S</creatorcontrib><creatorcontrib>BARRACLOUGH, R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ANANDAPPA, S. Y</au><au>WINSTANLEY, J. H. R</au><au>LEINSTER, S</au><au>GREEN, B</au><au>RUDLAND, P. S</au><au>BARRACLOUGH, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease</atitle><jtitle>British journal of cancer</jtitle><addtitle>Br J Cancer</addtitle><date>1994-04-01</date><risdate>1994</risdate><volume>69</volume><issue>4</issue><spage>772</spage><epage>776</epage><pages>772-776</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><coden>BJCAAI</coden><abstract>The messenger RNAs for the angiogenic acidic and basic fibroblast growth factors are expressed at a significantly higher level in samples of human benign neoplastic and hyperplastic tissue than in samples from breast cancers. However, approximately one in four malignant breast cancer samples contain basic fibroblast growth factor mRNA at the same level as in the benign lesions when basic fibroblast growth factor mRNA levels are corrected with respect to levels of expression of glyceraldehyde-3-phosphate dehydrogenase mRNA. A similar proportion of human malignant breast cancer cell lines express a high level of basic fibroblast growth factor mRNA. The results suggest that some malignant breast cancers and their constitutive carcinoma cells express abundant levels of basic fibroblast growth factor mRNA. The resultant production of basic fibroblast growth factor by breast cancer cells within some tumours may contribute to their development.</abstract><cop>Basingstoke</cop><pub>Nature Publishing Group</pub><pmid>7511406</pmid><doi>10.1038/bjc.1994.146</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-0920
ispartof British journal of cancer, 1994-04, Vol.69 (4), p.772-776
issn 0007-0920
1532-1827
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1968831
source MEDLINE; Nature; Springer Nature - Complete Springer Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Adult
Aged
Aged, 80 and over
Biological and medical sciences
Blotting, Northern
Breast Diseases - metabolism
Breast Neoplasms - chemistry
Breast Neoplasms - metabolism
DNA Probes
Female
Fibroblast Growth Factor 1 - biosynthesis
Fibroblast Growth Factor 2 - biosynthesis
Glyceraldehyde-3-Phosphate Dehydrogenases - biosynthesis
Gynecology. Andrology. Obstetrics
Humans
Mammary gland diseases
Medical sciences
Middle Aged
Poly A - analysis
RNA, Messenger - analysis
RNA, Neoplasm - analysis
Tumor Cells, Cultured
Tumors
title Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T03%3A12%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20expression%20of%20fibroblast%20growth%20factor%20mRNAs%20in%20benign%20and%20malignant%20breast%20disease&rft.jtitle=British%20journal%20of%20cancer&rft.au=ANANDAPPA,%20S.%20Y&rft.date=1994-04-01&rft.volume=69&rft.issue=4&rft.spage=772&rft.epage=776&rft.pages=772-776&rft.issn=0007-0920&rft.eissn=1532-1827&rft.coden=BJCAAI&rft_id=info:doi/10.1038/bjc.1994.146&rft_dat=%3Cproquest_pubme%3E76410652%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76410652&rft_id=info:pmid/7511406&rfr_iscdi=true